Patents by Inventor Kazuki Hashimoto

Kazuki Hashimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090118263
    Abstract: An adenine compound represented by the formula (1): (1) [wherein A1 and A2 each independently represents an (un)substituted aromatic carbocycle or (un)substituted aromatic heterocycle; L1, L2, and L3 each independently represents alkylene or a single bond, provided that any methylene or methine group in L2 or L3 may be bonded to the nitrogen atom adjacent to L2 and L3 to form a 4- to 7-membered saturated nitrogenous heterocycle; L4 represents alkylene or a single bond; R1 represents (un)substituted alkyl, (un)substituted aryl, etc.; R2 represents hydrogen or (un)substituted alkyl; R3 represents (un)substituted alkyl, etc.; and X represents oxygen, etc.] or a pharmaceutically acceptable salt of the compound. The compound and salt are useful as a medicine.
    Type: Application
    Filed: September 20, 2006
    Publication date: May 7, 2009
    Applicants: Dainippon Sumitomo Pharma Co., Ltd., ASTRAZENECA AKTIEBOLAG
    Inventors: Kazuki Hashimoto, Tomoaki Nakamura, Kei Nakamura, Ayumu Kurimoto, Yoshiaki Isobe
  • Publication number: 20090105212
    Abstract: A novel adenine compound represented by the formula (1): wherein A represents an (un)substituted aromatic carbocycle or (un)substituted aromatic heterocycle; L1, L2, and L3 each independently represents linear or branched alkylene, etc.; R1 represents (un)substituted alkyl, (un)substituted aryl, etc.; R2 represents hydrogen or (un) substituted alkyl; R3 represents (un)substituted alkyl, etc., provided that R3 may be bonded to L2 or L3 to form a nitrogenous saturated heterocycle; and X represents oxygen, etc.; or a pharmaceutically acceptable salt of the compound. The compound and salt are useful as a medicine.
    Type: Application
    Filed: September 22, 2006
    Publication date: April 23, 2009
    Applicants: Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan, AstraZeneca Aktiebolag a corporation of Sweden
    Inventors: Yoshiaki Isobe, Ayumu Kurimoto, Kazuki Hashimoto, Tomoaki Nakamura, Kei Nakamura
  • Publication number: 20080269240
    Abstract: An adenine compound useful as a medicine represented by the following formula (1): [wherein R1 is halogen atom, optionally substituted alkyl group, optionally substituted aryl group, etc.; X is oxygen atom, sulfur atom, a single bond, etc.; A1 is optionally substituted and optionally saturated 4 to 8 membered heterocyclic group containing 1 to 2 hetero atoms selected from 1 to 3 nitrogen atoms, 0 to 1 oxygen atom, and 0 to 1 sulfur atom; A2 is optionally substituted 6 to 10 cyclic aromatic hydrocarbon group or optionally substituted 5 to 10 membered heterocyclic aromatic group; L1 and L2 are independently, substituted straight or branched alkylene or a single bond, etc.; L3 is optionally substituted straight or branched alkylene, etc.; R2 is hydrogen atom, optionally substituted alkyl group.] or its pharmaceutically acceptable salt.
    Type: Application
    Filed: September 21, 2006
    Publication date: October 30, 2008
    Applicants: Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan, AstraZeneca Aktiebolag A Corporation of Sweden
    Inventors: Kazuki Hashimoto, Tomoaki Nakamura, Kei Nakamura, Shingo Tojo, Ayumu Kurimoto, Yoshiaki Isobe, Hiroki Wada, Roger Bonnert
  • Publication number: 20070225303
    Abstract: An 8-oxoadenine compound useful as an immuno-modulator having specific activity against Th1/Th2, specifically a prophylactic and therapeutic agent for a topical application for allergic diseases, viral diseases and cancers, which is represented by the following formula (1): wherein A is a group of a formula represented by the formula (2): wherein R2 is a substituted or unsubstituted alkyl group and so on, R3 is hydrogen atom or an alkyl group, R is a halogen atom and so on, n is 0˜2, X1 is oxygen atom, Z is straight or branched chain alkylene, and R1 is an alkyl group which is optionally substituted by hydroxy group, an alkoxy group, alkoxycarbonyl group and so on, or its pharmaceutically acceptable salt.
    Type: Application
    Filed: March 25, 2005
    Publication date: September 27, 2007
    Inventors: Haruhisa Ogita, Tomoaki Nakamura, Yoshiaki Isobe, Kazuki Hashimoto, Ayumu Kurimoto
  • Publication number: 20070190071
    Abstract: The present invention provides an 8-oxoadenine compound having immunemodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.
    Type: Application
    Filed: March 24, 2005
    Publication date: August 16, 2007
    Applicants: Dainippon Sumitomo Pharma Co., Ltd., AstraZeneca Aktiebolag
    Inventors: Ayumu Kurimoto, Kazuki Hashimoto, Yoshiaki Isobe, Stephen Brough, Ian Millichip, Hiroki Wada, Roger Bonnert, Thomas Mcinally
  • Patent number: 4902349
    Abstract: An asphalt/polyol emulsion is prepared from asphalt and polyol which are mixed and emulsified with a surface active agent and the plasticizer, by utilizing the behavior of a plasticizer according to the polymer solution theory and the surface-modifying effect of the plasticizer according to the surface chemistry.
    Type: Grant
    Filed: September 21, 1987
    Date of Patent: February 20, 1990
    Assignee: Toa Dora Kogyo Co., Ltd.
    Inventors: Saburo Wakizaka, Hiraku Hayasaka, Kazuki Hashimoto, Kentaro Shiojiri, Toshiaki Suzuki